82 related articles for article (PubMed ID: 9212903)
1. Rapid measurement of modified oligonucleotide levels in plasma samples with a fluorophore specific for single-stranded DNA.
Gray GD; Wickstrom E
Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):133-40. PubMed ID: 9212903
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.
Sands H; Gorey-Feret LJ; Cocuzza AJ; Hobbs FW; Chidester D; Trainor GL
Mol Pharmacol; 1994 May; 45(5):932-43. PubMed ID: 8190109
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic properties of several novel oligonucleotide analogs in mice.
Crooke ST; Graham MJ; Zuckerman JE; Brooks D; Conklin BS; Cummins LL; Greig MJ; Guinosso CJ; Kornbrust D; Manoharan M; Sasmor HM; Schleich T; Tivel KL; Griffey RH
J Pharmacol Exp Ther; 1996 May; 277(2):923-37. PubMed ID: 8627575
[TBL] [Abstract][Full Text] [Related]
4. Effect of phosphorothioate modifications on the ability of GTn oligodeoxynucleotides to specifically recognize single-stranded DNA-binding proteins and to affect human cancer cellular growth.
Morassutti C; Scaggiante B; Dapas B; Xodo L; Tell G; Quadrifoglio F
Biochimie; 1999 Dec; 81(12):1115-22. PubMed ID: 10607406
[TBL] [Abstract][Full Text] [Related]
5. Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond.
Boado RJ; Kang YS; Wu D; Pardridge WM
Drug Metab Dispos; 1995 Nov; 23(11):1297-300. PubMed ID: 8591734
[No Abstract] [Full Text] [Related]
6. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression.
Geary RS; Leeds JM; Fitchett J; Burckin T; Truong L; Spainhour C; Creek M; Levin AA
Drug Metab Dispos; 1997 Nov; 25(11):1272-81. PubMed ID: 9351904
[TBL] [Abstract][Full Text] [Related]
7. Comparative properties of a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in mice.
Hnatowich DJ; Mardirossian G; Fogarasi M; Sano T; Smith CL; Cantor CR; Rusckowski M; Winnard P
J Pharmacol Exp Ther; 1996 Jan; 276(1):326-34. PubMed ID: 8558450
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2'-O-methyl phosphodiester oligonucleotides in normal rats.
Lendvai G; Velikyan I; Bergström M; Estrada S; Laryea D; Välilä M; Salomäki S; Långström B; Roivainen A
Eur J Pharm Sci; 2005 Sep; 26(1):26-38. PubMed ID: 15941654
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats.
Geary RS; Watanabe TA; Truong L; Freier S; Lesnik EA; Sioufi NB; Sasmor H; Manoharan M; Levin AA
J Pharmacol Exp Ther; 2001 Mar; 296(3):890-7. PubMed ID: 11181921
[TBL] [Abstract][Full Text] [Related]
10. Development of an ultrasensitive noncompetitive hybridization-ligation enzyme-linked immunosorbent assay for the determination of phosphorothioate oligodeoxynucleotide in plasma.
Yu RZ; Baker B; Chappell A; Geary RS; Cheung E; Levin AA
Anal Biochem; 2002 May; 304(1):19-25. PubMed ID: 11969184
[TBL] [Abstract][Full Text] [Related]
11. Real-time monitoring of the hybridization reaction: application to the quantification of oligonucleotides in biological samples.
Boutet V; Delaunay V; De Oliveira MC; Boquet D; Grognet JM; Grassi J; Deverre JR
Biochem Biophys Res Commun; 2000 Feb; 268(1):92-8. PubMed ID: 10652219
[TBL] [Abstract][Full Text] [Related]
12. In vivo metabolic profile of a phosphorothioate oligodeoxyribonucleotide.
Temsamani J; Roskey A; Chaix C; Agrawal S
Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):159-65. PubMed ID: 9212906
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 nucleocapsid protein as a nucleic acid chaperone: spectroscopic study of its helix-destabilizing properties, structural binding specificity, and annealing activity.
Urbaneja MA; Wu M; Casas-Finet JR; Karpel RL
J Mol Biol; 2002 May; 318(3):749-64. PubMed ID: 12054820
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and metabolism of an oligodeoxynucleotide phosphorothioate (GEM91) in cynomolgus monkeys following intravenous infusion.
Grindel JM; Musick TJ; Jiang Z; Roskey A; Agrawal S
Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):43-52. PubMed ID: 9512095
[TBL] [Abstract][Full Text] [Related]
15. Toxicity and toxicokinetics of a phosphorothioate oligonucleotide against the c-myc oncogene in cynomolgus monkeys.
Webb MS; Tortora N; Cremese M; Kozlowska H; Blaquiere M; Devine DV; Kornbrust DJ
Antisense Nucleic Acid Drug Dev; 2001 Jun; 11(3):155-63. PubMed ID: 11446591
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
Agrawal S; Temsamani J; Tang JY
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7595-9. PubMed ID: 1881900
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides.
Sands H; Gorey-Feret LJ; Ho SP; Bao Y; Cocuzza AJ; Chidester D; Hobbs FW
Mol Pharmacol; 1995 Mar; 47(3):636-46. PubMed ID: 7700261
[TBL] [Abstract][Full Text] [Related]
18. Conformational change in the herpes simplex single-strand binding protein induced by DNA.
Dudas KC; Scouten SK; Ruyechan WT
Biochem Biophys Res Commun; 2001 Oct; 288(1):184-90. PubMed ID: 11594771
[TBL] [Abstract][Full Text] [Related]
19. Fast separation of single-stranded oligonucleotides by capillary electrophoresis using OliGreen as fluorescence inducing agent.
Zhang J; Liang D; He W; Wan F; Ying Q; Chu B
Electrophoresis; 2005 Dec; 26(23):4449-55. PubMed ID: 16315172
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice.
Saijo Y; Perlaky L; Wang H; Busch H
Oncol Res; 1994; 6(6):243-9. PubMed ID: 7865900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
